The Inova Type 2 Diabetes Mellitus Study

NCT02222623 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants enrolled

Conditions

Diabetes, Type 2

Interventions

DRUG: Glargine
DRUG: NPH

Sponsor

Inova Health Care Services